Table 2.
Demographic characteristics and clinical characteristics of patients at baseline.
| Patients | Antiwei | Placebo | P |
|---|---|---|---|
| Population with influenza-like illness | |||
| n | 353 | 114 | |
| Age (years) | 37.8 ± 12.6 | 38.6 ± 12.3 | 0.573 |
| Gender (Male/female) | 142/211 | 47/67 | 0.850 |
| Duration (hours) | 18.4 ± 8.1 | 18.7 ± 7.7 | 0.756 |
| Total symptom score (points)a | 20.1 ± 5.4 | 20.4 ± 5.5 | 0.566 |
| Axillary temperature (°C) | 38.03 ± 0.44 | 37.94 ± 0.41 | 0.065 |
| Influenza-confirmed population | |||
| n | 177 | 48 | |
| Influenza A, B or both A and B | 99/60/18 | 26/14/8 | 0.437 |
| Age (years) | 37.3 ± 12.3 | 35.9 ± 12.8 | 0.480 |
| Gender (Male/female) | 72/105 | 23/25 | 0.368 |
| Duration (hours) | 18.8 ± 8.3 | 18.5 ± 7.4 | 0.828 |
| Total symptom score (points)a | 20.2 ± 5.3 | 19.6 ± 5.0 | 0.500 |
| Axillary’s temperature (°C) | 38.05 ± 0.44 | 37.95 ± 0.47 | 0.168 |
a
Total symptom scores include cough, sore throat, nasal symptoms (nasal obstruction and rhinorrhoea), headache, fatigue, myalgia, thirst and chills assessed by a four-point scale (0 absent, 1 mild, 2 moderate, and 3 severe). Numerical variables are presented as Mean ± SD.